It is well known that bradykinin increases vascular permeability, causing fluid extravasation,6 and it is therefore plausible that the severe acute respiratory distress syndrome (ARDS), including pulmonary edema, seen in severe cases of COVID-19, is caused at least in part by the bradykinin storm.8 Here, KNG1 is linked to acute respiratory distress syndrome.